Cargando…

An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III

BACKGROUND: Mucopolysaccharidosis type-III (MPS III) is an autosomal recessive lysosomal storage disorder. It causes progressive physical and cognitive decline and has been linked to increased incidences of behavioural problems. METHODS: Data on the behaviour and adaptive skills of 20 children with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cross, Elaine M, Grant, Sheena, Jones, Simon, Bigger, Brian W, Wraith, James E, Mahon, Louise V, Lomax, Michelle, Hare, Dougal J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318134/ https://www.ncbi.nlm.nih.gov/pubmed/25657821 http://dx.doi.org/10.1186/1866-1955-6-46

Ejemplares similares

Assessment of Sleep in Children with Mucopolysaccharidosis Type III
por: Mahon, Louise Victoria, et al.
Publicado: (2014)

Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Mumford, Rachel A., et al.
Publicado: (2015)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
por: Ghosh, Arunabha, et al.
Publicado: (2017)

Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
por: Langford-Smith, Alex, et al.
Publicado: (2011)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II
por: Gleitz, Hélène F. E., et al.
Publicado: (2017)

Novel therapies for mucopolysaccharidosis type III
por: Seker Yilmaz, Berna, et al.
Publicado: (2020)

Abstract for E- poster Mucopolysaccharidosis III (Sanfilippo Syndrome) with severe behavioural problems
Publicado: (2022)

Heparan Sulfate Inhibits Hematopoietic Stem and Progenitor Cell Migration and Engraftment in Mucopolysaccharidosis I
por: Watson, H. Angharad, et al.
Publicado: (2014)

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II
por: Schulze-Frenking, G., et al.
Publicado: (2010)

Hip pathologies in mucopolysaccharidosis type III
por: Breyer, Sandra Rafaela, et al.
Publicado: (2021)

Mucopolysaccharidosis III: Molecular basis and treatment
por: Spahiu, Lidvana, et al.
Publicado: (2021)

Airway-Related Symptoms and Surgeries in Patients With Mucopolysaccharidosis I
por: Arn, Pamela, et al.
Publicado: (2015)

Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
por: Horgan, Claire, et al.
Publicado: (2022)

Phenotypic expansion of ARSK ‐related mucopolysaccharidosis
por: Rustad, Cecilie F., et al.
Publicado: (2022)

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
por: Moore, David, et al.
Publicado: (2008)

Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I
por: Ghosh, Arunabha, et al.
Publicado: (2019)

Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy
por: Pal, Abhijit Ricky, et al.
Publicado: (2018)

Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey
por: Link, Bianca, et al.
Publicado: (2010)

Prediction of phenotypic severity in mucopolysaccharidosis type IIIA
por: Knottnerus, Suzan J. G., et al.
Publicado: (2017)

RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis
por: Wiesinger, Anna-Maria, et al.
Publicado: (2023)

A rare late progression form of Sly syndrome mucopolysaccharidosis
por: Guffon, Nathalie, et al.
Publicado: (2019)

Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Valstar, Marlies J, et al.
Publicado: (2011)

Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III)
por: Muschol, Nicole M., et al.
Publicado: (2019)

The neurobehavioral phenotype in mucopolysaccharidosis Type IIIB: An exploratory study
por: Shapiro, E., et al.
Publicado: (2016)

Phenotype prediction for mucopolysaccharidosis type I by in silico analysis
por: Ou, Li, et al.
Publicado: (2017)

Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC
por: O’Leary, Claire, et al.
Publicado: (2023)

Protein Misfolding as an Underlying Molecular Defect in Mucopolysaccharidosis III Type C
por: Feldhammer, Matthew, et al.
Publicado: (2009)

Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature
por: Thomas, Sophie, et al.
Publicado: (2021)

Sleep-related hypermotor epilepsy in a patient with mucopolysaccharidosis type III
por: Abramova, Anna A., et al.
Publicado: (2021)

Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III
por: Kim, Min-Sun, et al.
Publicado: (2022)

Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
por: Brands, Marion M, et al.
Publicado: (2013)

A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis
por: Zapała, Barbara, et al.
Publicado: (2020)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission
por: Pará, Camila, et al.
Publicado: (2021)

Neurological, neurobehavioral, and radiological alterations in patients with mucopolysaccharidosis III (Sanfilippo's syndrome) in Brazil
por: do Valle, Daniel Almeida, et al.
Publicado: (2022)

Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
por: de Bode, Chiel J., et al.
Publicado: (2022)

Haematopoietic stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA
por: Parker, Helen, et al.
Publicado: (2020)

Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I)
por: Barbosa Mendes, Ana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_orsn393g3oc9iu5lajiop4snef